Featured White Papers
- Enterprise PBX buyer's guide (VoIP-News)
- Enterprise PBX comparison guide (VoIP-News)
- Hosted CRM buyer's guide (Inside CRM)
Market Alert: UDTT Is Still on the Move!
Market Wire, April, 2008
Wall Street Press Wire ( www.WallStreetPressWire.com ) is please to highlight its "stocks on the move" for Tuesday. Our list includes: Universal Detection Technology (OTCBB: UDTT), Vertex Pharmaceuticals Inc. (NASDAQ: VRTX), Wyeth (NYSE: WYE) and Lockheed Martin Corporation (NYSE: LMT).
Wall Street Press Wire is continuing its in-depth coverage of Universal Detection Technology (OTCBB: UDTT), a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats, and a provider of counter-terrorism consulting and training services.
Tuesday after the markets closed, the company issued an important press release announcing that that it has received a purchase order from an Israeli company for Company's Hand Held Assays (HHA).
This news should be welcomed by the company and its investors! The Israeli government, as well as private security firms are actively improving their preparedness for a bioterror attack as the potential threat of such an attack from terror organizations and states with active biological weapon programs, such as Syria, grows. As an example, large numbers of the Israeli population have received smallpox inoculations.
UDTT's anthrax detection HHAs have provided accurate results to users in the field in as little as three minutes. The assays have been purchased by first responders throughout the country as well as the U.S. Army. The kits are able to detect anthrax spores well below the threshold for an infectious dose.
"We have seen increased interest in our bioterrorism detection kits recently from Israeli security firms and we hope that this trend can open up doors to more international sales of UDTT's HHAs," said Mr. Jacques Tizabi, UDTT's Chief Executive Officer.
Wall Street Press Wire's in-depth profile for Universal Detection Technology is available at: http://www.wallstreetpresswire.com/page.php?BN_UID=38
The stock closed Monday at under a Penny a share.
About the company: UDTT is a supplier of counter terrorism services and technologies to private and government organizations. The Company owns the license to a patented technology developed at NASA's JPL and utilized in UDTT's BSM-2000 used for autonomous monitoring of the air for presence of airborne bacterial spores such as anthrax. UDTT also supplies detection kits for detection of up to 5 bioterrorism agents. Among the Company's other products are radiation detection systems, educational material & training DVDs, and antimicrobial chemicals.
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) up 2.5% on 4.1 million shares traded.
Vertex Pharmaceuticals Incorporated is a global biotechnology company committed to the discovery and development of breakthrough small molecule drugs for serious diseases.
Wyeth (NYSE: WYE) down 0.5% on 5.6 million shares traded.
Wyeth is one of the world's largest research-driven pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing, and marketing of pharmaceuticals, vaccines, biotechnology products, and non-prescription medicines that improve the quality of life for people worldwide.
Lockheed Martin Corporation (NYSE: LMT) down 2.6% on 2.1 million shares traded.
Lockheed Martin employs approximately 140,000 people worldwide and is principally engaged in the research, design, development, manufacture, integration and sustainment of advanced technology systems, products and services.
Wall Street Press Wire:
Wall Street Press Wire (WSPW) is the premiere online financial destination of choice for today's investment community, and a leading provider of online press release distribution and a disseminator of electronic information. From Wall Street to Main Street, our goal is to bridge the gap between emerging publicly traded companies and shareholders across the country.
With many small publicly traded companies operating under the radar of mainstream Wall Street, our service places their news story in front of the eyes of the investment community. Utilizing a targeted distribution approach, their story reaches the top news websites on the web and thousands of investors nationwide. For more information on our products, please visit: http://www.wallstreetpresswire.com/content.php?UID=5
Wall Street Press Wire (WSPW) is a division of Wall Street Capital Funding LLC (WSCF). WSCF also maintains a contractual, working relationship with Stock Market Alerts LLC and its' Wall Street Enews brand. WSPW is not a registered broker/dealer and may not sell, offer to sell or offer to buy any security. WSPW profiles are not a solicitation or recommendation to buy, sell or hold securities. An offer to buy or sell can be made only with accompanying disclosure documents from the company offering or selling securities and only in the states and provinces for which they are approved. The material in this release is intended to be strictly informational. The companies that are discussed in this release have not approved the statements made in this release nor approved the timing of this release. All statements and expressions are the sole opinion of WSPW and are subject to change without notice. Information in this release is derived from a variety of sources including that company's publicly disseminated information, third parties and WSPW research. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. WSPW disclaims any and all liability as to the completeness or accuracy of the information contained and any omissions of material fact in this release. The release may contain technical inaccuracies or typographical errors. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. Investment in the securities of the companies' discussed in this release is highly speculative and carries a high degree of risk. WSPW is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment if they make a purchase in WSPW profiled stocks.